These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1214504)

  • 41. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
    Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
    Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic studies in patients with hepatic cirrhosis and portal hypertension].
    Tan YQ
    Zhonghua Wai Ke Za Zhi; 1983 May; 21(5):278-80. PubMed ID: 6628111
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
    Marra F; Pinzani M
    Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
    [No Abstract]   [Full Text] [Related]  

  • 44. Pressure profile in liver sinusoids. A model of localization of sinusoidal resistance in the normal and cirrhotic liver.
    Henriksen JH; Lassen NA
    Liver; 1988 Apr; 8(2):88-94. PubMed ID: 3367712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of lymphatics in the formation of ascites complicating schistosomal hepatic fibrosis.
    Ismail AM; Aboul-Enein A
    Lymphology; 1976 Jun; 9(2):43-6. PubMed ID: 957764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic venous pressure gradient in 2010: optimal measurement is key.
    Burroughs AK; Thalheimer U
    Hepatology; 2010 Jun; 51(6):1894-6. PubMed ID: 20512984
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of the functional state of the liver in cirrhosis and extrahepatic portal hypertension].
    Lytkin MI; Vlasov VS; Eriukhin IA
    Khirurgiia (Mosk); 1975 Jan; (1):56-62. PubMed ID: 1110533
    [No Abstract]   [Full Text] [Related]  

  • 48. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemodynamic and functional aspects of portal hypertension decompensation in liver cirrhosis].
    Kalita NIa; Kotenko OG; Bulanov KI; Furmanenko ED; Egorova OE
    Klin Khir (1962); 1994; (11):37-41. PubMed ID: 7658658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Doppler blood flow measurements in the portal system].
    Kalina Z; Scieszka J; Maślankiewicz A
    Pol Przegl Radiol; 1988; 52(6):284-6. PubMed ID: 3077452
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of spleen enlargement in cirrhosis with portal hypertension.
    Bolognesi M; Merkel C; Sacerdoti D; Nava V; Gatta A
    Dig Liver Dis; 2002 Feb; 34(2):144-50. PubMed ID: 11926560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant role of intrahepatic shunt in hepatic function test with the use of dye in cirrhosis.
    Horisawa M
    Nagoya J Med Sci; 1979 Mar; 41(1-4):1-8. PubMed ID: 460392
    [No Abstract]   [Full Text] [Related]  

  • 53. [Functional activity of the thrombocytes under conditions of hypersplenism and portal hypertension in liver cirrhosis].
    Makarevich IaA; Kosterova VV; Podobedov GM; Shamshev VM
    Ter Arkh; 1976; 48(3):15-9. PubMed ID: 1006533
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute-on-chronic liver failure: the liver and portal haemodynamics.
    Mookerjee RP
    Curr Opin Crit Care; 2011 Apr; 17(2):170-6. PubMed ID: 21346568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 56. [Functional nephropathy in the course of hepatic cirrhosis. Pathogenetic relationships with changes in hepatic blood flow].
    Merkel C; Zuin R; Grassetto M; Milani L; Merlo A; Gatta A
    Minerva Nefrol; 1979; 26(1):33-6. PubMed ID: 381989
    [No Abstract]   [Full Text] [Related]  

  • 57. Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension.
    Witte CL; Witte MH; Dumont AE; Frist J; Cole WR
    Ann Surg; 1968 Oct; 168(4):567-77. PubMed ID: 5687537
    [No Abstract]   [Full Text] [Related]  

  • 58. [Complications of portal hypertension in the liver cirrhosis].
    Ivashkin VT
    Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1074-92. PubMed ID: 19957897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous determination of liver blood flow and polygonal cell function in hepatobiliary diseases.
    Bláha V; Kolínská J; Blahníková L; Endrle E; Sousek O; Výska K
    Nucl Med (Stuttg); 1969 Apr; 8(1):22-34. PubMed ID: 5795620
    [No Abstract]   [Full Text] [Related]  

  • 60. Emerging therapies for portal hypertension in cirrhosis.
    Nair H; Berzigotti A; Bosch J
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):167-81. PubMed ID: 27148904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.